Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Burzynski Research Institute Inc BZYR

Healthcare Biotechnology
Burzynski Research Institute, Inc. is engaged in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids, which are known under the trade name Antineoplastons. Antineoplastons are useful in the treatment of human cancer and is reviewing data from its Phase II clinical trials of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:BZYR)

Burzynski Research Institute, Inc. Announces the Launch of a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma

Business Wire April 14, 2016

A Look at Four Brain Cancer Companies for 2016

Accesswire January 4, 2016

Burzynski Research Institute, Inc. Announces Favorable Objective Response Rates and Overall Survival in Adults with Anaplastic Astrocytoma Following Antineoplastons A-10 and AS2-1

Business Wire December 7, 2015

Burzynski Research Institute, Inc. Announces Publications Documenting Long-term Survival in Malignant Brain Tumors Following Antineoplaston Therapy

PR Newswire October 26, 2015

Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Adults with Recurrent Anaplastic Astrocytoma

Business Wire June 18, 2015

Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Adults with Newly-Diagnosed Anaplastic Astrocytoma

Business Wire March 31, 2015

Burzynski Research Institute, Inc. Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the Liver

PR Newswire March 26, 2015

Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma

PR Newswire October 24, 2014

Burzynski Research Institute, Inc. Announces Presentations at the 16th International Symposium on Pediatric Neuro-Oncology

PR Newswire June 27, 2014
View More News ››

Opinion & Analysis (OTCPK:BZYR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:BZYR)

Be the first to post on this bullboard.

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is a Canadian-based international oil and gas exploration company. The Company is focused on oil and gas ...
View More »